Accessibility Menu
Marpai logo

Marpai(OTC) MRAI

Market Cap$56.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-88%
5 YearN/A
1 Year+71%
1 Month+213%
$2.24
-5.49%
-0.13Today
Marpai last closing stock price
MetricPriceDate
Last closeUSD 2.242026-07-27
Marpai stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.44%USD 2.252026-07-20
1 month+213.24%USD 0.722026-06-26
3 month+767.88%USD 0.262026-04-28
Year to date+254.99%USD 0.632025-12-31
1 year+70.99%USD 1.312025-07-25
3 year+27.27%USD 1.762023-07-28
Since inception-88.21%USD 19.002021-10-27

Marpai Financials at a Glance

Market Cap

$56.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$17.13M

Net Income (TTM)

-$16.67M

EPS (TTM)

-$0.88

P/E Ratio

-2.55

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.24

Volume

67,544

Open

$2.33

Previous Close

$2.24

Daily Range

$2.21 - $2.38

52-Week Range

$0.22 - $2.50

Estimated Earnings Date

Aug 12, 2026

MRAI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Marpai

Marpai helps employers manage health benefits for their workers. Its services aim to lower healthcare costs and improve care quality. The company uses technology to predict and prevent costly medical events for employees.

Products and Services

  • Health Plan Administration: Manages self-insured employer health plans, including claims processing and member support.
  • Care Management: Offers nurse-led guidance to help employees navigate complex medical needs.
  • Pharmacy Benefit Management: Provides transparent drug pricing and rebate disclosure through MarpaiRx.
  • Cost Containment: Uses analytics to identify and reduce unnecessary or overpriced care.
  • Digital Tools: myMarpai app helps members track benefits and access support easily.

Growth and Expansion

  • Consolidated claims processing onto a single cloud-based platform in 2026 for efficiency.
  • Raised capital through multiple private placements in 2025, including insider participation.
  • Restructured operations in 2026, reducing workforce and software contracts to cut costs.

What Makes Marpai Stand Out

Marpai focuses on small and mid-sized employers seeking control over healthcare costs. Its technology-driven approach uses data to guide care and reduce waste. The company’s integrated platform aims to streamline administration and improve member experience.

Five Things You Need to Know

  • Revenue was $18.1 million in 2025, down 36% from 2024.
  • Net loss was $16.6 million in 2025, improved from $22.1 million in 2024.
  • Customer attrition reached 28% in 2025, impacting revenue stability.
  • Short-term debt was $11.0 million and long-term debt $17.2 million at 2025 year-end.
  • Auditor raised substantial doubt about Marpai’s ability to continue as a going concern in 2025.

Bottom Line

Marpai has shifted toward technology-driven healthcare administration for self-insured employers. The company faces financial challenges but continues to adapt its business model and operations.

AI Generated • Apr 16, 2026

Industry

Insurance

Employees

107

CEO

Damien Francis Lamendola, MBA

Headquarters

Tampa, FL 10016, US

MRAI Financials

Key Financial Metrics (TTM)

Gross Margin

23.31%

Operating Margin

-80.40%

Net Income Margin

-97.37%

Return on Equity

49.95%

Return on Capital

N/A

Return on Assets

-152.76%

Earnings Yield

-39.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$56.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

25.29M

Volume

67.54K

Avg. Volume

83.44K

Financials (TTM)

Gross Profit

$3.99M

Operating Income

-$13.77M

EBITDA

-$13.28M

Operating Cash Flow

-$7.82M

Capital Expenditure

$0.00

Free Cash Flow

-$7.82M

Cash & ST Invst.

$201.00K

Total Debt

$730.00K

Marpai Performance Analysis

Marpai annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 24,341,87471.1%
20232023-12-31USD 37,155,05052.6%
20242024-12-31USD 28,173,000-24.2%
20252025-12-31USD 18,099,000-35.8%
Marpai sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-14.1%
Q32025-09-30-13.3%
Q42025-12-31-1.2%
Q12026-03-3111.4%
Marpai annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -5.2366.1%
20232023-12-31USD -4.14-20.9%
20242024-12-31USD -1.92-53.6%
20252025-12-31USD -0.95-50.3%
Marpai sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-33.3%
Q32025-09-3028.6%
Q42025-12-31-30.0%
Q12026-03-3150.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$4.44M

-18.0%

Gross Profit

$1.21M

-37.7%

Gross Margin

27.12%

N/A

Market Cap

$56.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$529.49K

N/A

Employees

107

N/A

Net Income

-$3.18M

-3.7%

EBITDA

-$2.42M

-13.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$201.00K

-72.4%

Total Debt

$730.00K

-25.4%

Accounts Receivable

$1.43M

+93.1%

Inventory

$0.00

N/A

Long Term Debt

$457.00K

-37.4%

Short Term Debt

$273.00K

+10.1%

Return on Assets

-1.53%

N/A

Return on Invested Capital

84.83%

N/A

Free Cash Flow

-$477.00K

-314.8%

Operating Cash Flow

-$477.00K

-314.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBLPGlobal Pharmatech, Inc.
$0.08+0.00%
POSCPositron Corporation
$1.57-6.55%
DGNOFDIAGNOS Inc.
$0.15-6.25%
CNTMFFluent Corp.
$0.02-4.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%
TAT&T
$24.42+0.01%

Questions About MRAI

What is the current price of Marpai?

Marpai is trading at $2.24 per share.

What is the 52-week range for Marpai?

Over the past 52 weeks, Marpai has traded between $0.22 and $2.50.

How much debt does Marpai have?

As of the most recent reporting period, Marpai reported total debt of $9.71M.

How much cash does Marpai have on hand?

Marpai reported $8.63M in cash and cash equivalents in its most recent financial results.

What is Marpai’s dividend yield?

Marpai does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.